Request Deal Involvement

Catalio Capital Management, Third Rock Ventures and Novo led a $150m Series A funding round in Clasp Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ten Bridge Communications

pr advisors

Ten Bridge Communications

or

Principals

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

CURE VENTURES

bidder

CURE VENTURES

CLASP THERAPEUTICS

target

CLASP THERAPEUTICS

BLACKBIRD BIOVENTURES

bidder

BLACKBIRD BIOVENTURES

THIRD ROCK VENTURES LLC

bidder

THIRD ROCK VENTURES LLC

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

PICTET ALTERNATIVE ADVISORS

bidder

PICTET ALTERNATIVE ADVISORS

VIVO CAPITAL LLC

bidder

VIVO CAPITAL LLC

AMERICAN CANCER SOCIETY’S BRIGHT EDGE

bidder

AMERICAN CANCER SOCIETY’S BRIGHT EDGE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Catalio Capital Management, Third Rock Ventures and Novo led a $150m Series A funding round in Clasp Therapeutics.